TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MEDX Stock 12 Month Forecast
Average Price Target
CHF16.00
▲(75.44% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for medmix AG in the last 3 months. The average price target is CHF16.00 with a high forecast of CHF16.00 and a low forecast of CHF16.00. The average price target represents a 75.44% change from the last price of CHF9.12.
Copying Patrick Rafaisz's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +10.30% per trade.
Copying Patrick Rafaisz's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -7.10% per trade.
Copying Patrick Rafaisz's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -6.15% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MEDX Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
1
1
1
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
1
1
1
0
In the current month, MEDX has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. MEDX average Analyst price target in the past 3 months is 16.00.
Each month's total comprises the sum of three months' worth of ratings.
MEDX Financial Forecast
MEDX Earnings Forecast
The previous quarter’s earnings for MEDX were CHF0.33.
The previous quarter’s earnings for MEDX were CHF0.33.
MEDX Sales Forecast
Next quarter’s sales forecast for MEDX is CHF231.00M with a range of CHF231.00M to CHF231.00M. The previous quarter’s sales results were CHF222.60M. MEDX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MEDX has Performed in-line its overall industry.
Next quarter’s sales forecast for MEDX is CHF231.00M with a range of CHF231.00M to CHF231.00M. The previous quarter’s sales results were CHF222.60M. MEDX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year MEDX has Performed in-line its overall industry.
MEDX Stock Forecast FAQ
What is CH:MEDX’s average 12-month price target, according to analysts?
Based on analyst ratings, medmix AG’s 12-month average price target is 16.00.
What is CH:MEDX’s upside potential, based on the analysts’ average price target?
medmix AG has 75.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is medmix AG a Buy, Sell or Hold?
medmix AG has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is medmix AG’s share price target?
The average share price target for medmix AG is 16.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF16.00 ,and the lowest forecast is CHF16.00. The average share price target represents 75.44% Increase from the current price of CHF9.12.
What do analysts say about medmix AG?
medmix AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of medmix AG?
To buy shares of CH:MEDX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.